These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 33453388)

  • 1. Enhanced oral bioavailability of nintedanib esylate with nanostructured lipid carriers by lymphatic targeting: In vitro, cell line and in vivo evaluation.
    Patel P; Patel M
    Eur J Pharm Sci; 2021 Apr; 159():105715. PubMed ID: 33453388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanostructured lipid carriers as oral delivery systems for improving oral bioavailability of nintedanib by promoting intestinal absorption.
    Zhu Y; Liang X; Lu C; Kong Y; Tang X; Zhang Y; Yin T; Gou J; Wang Y; He H
    Int J Pharm; 2020 Aug; 586():119569. PubMed ID: 32592899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
    Dudhipala N; Janga KY; Gorre T
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, characterization, and
    Saghafi Z; Mohammadi M; Mahboobian MM; Derakhshandeh K
    Drug Dev Ind Pharm; 2021 Mar; 47(3):509-520. PubMed ID: 33650445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
    Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
    J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cell-penetrating peptide-coated nanostructured lipid carriers on the oral absorption of tripterine.
    Chen Y; Yuan L; Zhou L; Zhang ZH; Cao W; Wu Q
    Int J Nanomedicine; 2012; 7():4581-91. PubMed ID: 22942642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis.
    Deng J; Wu Z; Zhao Z; Wu C; Yuan M; Su Z; Wang Y; Wang Z
    Int J Nanomedicine; 2020; 15():3937-3951. PubMed ID: 32581538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
    Li H; Chen M; Su Z; Sun M; Ping Q
    Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eudragit S-100 Surface Engineered Nanostructured Lipid Carriers for Colon Targeting of 5-Fluorouracil: Optimization and In Vitro and In Vivo Characterization.
    Borderwala K; Rathod S; Yadav S; Vyas B; Shah P
    AAPS PharmSciTech; 2021 Aug; 22(6):216. PubMed ID: 34386888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality by design (QbD)-based fabrication of atazanavir-loaded nanostructured lipid carriers for lymph targeting: bioavailability enhancement using chylomicron flow block model and toxicity studies.
    Gurumukhi VC; Bari SB
    Drug Deliv Transl Res; 2022 May; 12(5):1230-1252. PubMed ID: 34110597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipids-based nanostructured lipid carriers (NLCs) for improved oral bioavailability of sirolimus.
    Yu Q; Hu X; Ma Y; Xie Y; Lu Y; Qi J; Xiang L; Li F; Wu W
    Drug Deliv; 2016 May; 23(4):1469-75. PubMed ID: 27187522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanostructured lipid carriers with exceptional gastrointestinal stability and inhibition of P-gp efflux for improved oral delivery of tilmicosin.
    Zhang Q; Yang H; Sahito B; Li X; Peng L; Gao X; Ji H; Wang L; Jiang S; Guo D
    Colloids Surf B Biointerfaces; 2020 Mar; 187():110649. PubMed ID: 31767412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of Mirabegron-loaded Nanostructured Lipid Carriers for Improved Bioabsorption: Formulation, Statistical Optimization, and In-Vivo Evaluation.
    Shah P; Patel M; Kansara Y; Vyas B; Prajapati P; Pradhan M; Jain S
    AAPS PharmSciTech; 2024 Sep; 25(7):222. PubMed ID: 39322792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribociclib Nanostructured Lipid Carrier Aimed for Breast Cancer: Formulation Optimization, Attenuating
    Sartaj A; Annu ; Biswas L; Verma AK; Sahoo PK; Baboota S; Ali J
    Biomed Res Int; 2022; 2022():6009309. PubMed ID: 35155677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of Ergosterol-Loaded Nanostructured Lipid Carriers for Enhancing Oral Bioavailability and Antidiabetic Nephropathy Effects.
    Dong Z; Iqbal S; Zhao Z
    AAPS PharmSciTech; 2020 Jan; 21(2):64. PubMed ID: 31932990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QbD-driven development of phospholipid-embedded lipidic nanocarriers of raloxifene: extensive in vitro and in vivo evaluation studies.
    Pant A; Sharma G; Saini S; Kaur G; Jain A; Thakur A; Singh B
    Drug Deliv Transl Res; 2024 Mar; 14(3):730-756. PubMed ID: 37768530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid-coated cationic nanostructured lipid carriers for oral vincristine sulfate delivery.
    Gao X; Zhang J; Xu Q; Huang Z; Wang Y; Shen Q
    Drug Dev Ind Pharm; 2017 Apr; 43(4):661-667. PubMed ID: 28043185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies to enhance oral delivery of amphotericin B: a comparison of uncoated and enteric-coated nanostructured lipid carriers.
    Nimtrakul P; Sermsappasuk P; Tiyaboonchai W
    Drug Deliv; 2020 Dec; 27(1):1054-1062. PubMed ID: 32633144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks.
    Elmowafy M; Ibrahim HM; Ahmed MA; Shalaby K; Salama A; Hefesha H
    Drug Deliv; 2017 Nov; 24(1):932-941. PubMed ID: 28617150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asenapine maleate-loaded nanostructured lipid carriers: optimization and in vitro, ex vivo and in vivo evaluations.
    Managuli RS; Wang JT; Faruqu FN; Kushwah V; Raut SY; Shreya AB; Al-Jamal KT; Jain S; Mutalik S
    Nanomedicine (Lond); 2019 Apr; 14(7):889-910. PubMed ID: 30874464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.